Patents by Inventor Todd Jeffrey Brinton

Todd Jeffrey Brinton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF PLATELET RICH PLASMA COMPOSITION IN THE TREATMENT OF CARDIAC CONDUCTION ABNORMALITIES
    Publication number: 20240082301
    Abstract: Methods and kits for treating a cardiac arrhythmia using a platelet rich plasma (PRP) composition are provided. Any type of arrhythmia may be treated using the PRP composition. The PRP composition may comprise PRP developed using blood collected from a patient suffering the cardiac arrhythmia. The PRP composition may be buffered to a physiological pH and may include one or more anti-arrhythmic agents, anti-coagulants, or other drugs. The PRP composition may be delivered using a nebulizer, minimally invasively, or surgically.
    Type: Application
    Filed: March 30, 2023
    Publication date: March 14, 2024
    Inventors: Allan Kumar Mishra, Todd Jeffrey Brinton
  • Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities
    Patent number: 11638548
    Abstract: Methods and kits for treating a cardiac arrhythmia using a platelet rich plasma (PRP) composition are provided. Any type of arrhythmia may be treated using the PRP composition. The PRP composition may comprise PRP developed using blood collected from a patient suffering the cardiac arrhythmia. The PRP composition may be buffered to a physiological pH and may include one or more anti-arrhythmic agents, anti-coagulants, or other drugs. The PRP composition may be delivered using a nebulizer, minimally invasively, or surgically.
    Type: Grant
    Filed: October 16, 2018
    Date of Patent: May 2, 2023
    Assignee: Blue Engine Biologies, LLC
    Inventors: Allan Kumar Mishra, Todd Jeffrey Brinton
  • Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities
    Patent number: 9351999
    Abstract: Methods and kits for treating a cardiac arrhythmia using a platelet rich plasma (PRP) composition are provided. Any type of arrhythmia may be treated using the PRP composition. The PRP composition may comprise PRP developed using blood collected from a patient suffering the cardiac arrhythmia. The PRP composition may be buffered to a physiological pH and may include one or more anti-arrhythmic agents, anti-coagulants, or other drugs. The PRP composition may be delivered using a nebulizer, minimally invasively, or surgically.
    Type: Grant
    Filed: August 29, 2014
    Date of Patent: May 31, 2016
    Inventors: Allan Kumar Mishra, Todd Jeffrey Brinton
  • USE OF PLATELET RICH PLASMA COMPOSITION IN THE TREATMENT OF CARDIAC CONDUCTION ABNORMALITIES
    Publication number: 20150037431
    Abstract: Methods and kits for treating a cardiac arrhythmia using a platelet rich plasma (PRP) composition are provided. Any type of arrhythmia may be treated using the PRP composition. The PRP composition may comprise PRP developed using blood collected from a patient suffering the cardiac arrhythmia. The PRP composition may be buffered to a physiological pH and may include one or more anti-arrhythmic agents, anti-coagulants, or other drugs. The PRP composition may be delivered using a nebulizer, minimally invasively, or surgically.
    Type: Application
    Filed: August 29, 2014
    Publication date: February 5, 2015
    Inventors: Allan Kumar Mishra, Todd Jeffrey Brinton
  • USE OF PLATELET RICH PLASMA COMPOSITION IN THE TREATMENT OF CARDIAC CONDUCTION ABNORMALITIES
    Publication number: 20100112081
    Abstract: Methods and kits for treating a cardiac arrhythmia using a platelet rich plasma (PRP) composition are provided. Any type of arrhythmia may be treated using the PRP composition. The PRP composition may comprise PRP developed using blood collected from a patient suffering the cardiac arrhythmia. The PRP composition may be buffered to a physiological pH and may include one or more anti-arrhythmic agents, anti-coagulants, or other drugs. The PRP composition may be delivered using a nebulizer, minimally invasively, or surgically. In some embodiments, the PRP composition may be coated on one or more medical devices. The PRP composition may be delivered to an identified portion of the electrical conduction system of the heart affected and/or causing the arrhythmia to occur.
    Type: Application
    Filed: October 7, 2009
    Publication date: May 6, 2010
    Applicant: BioParadox, LLC
    Inventors: Allan Kumar Mishra, Todd Jeffrey Brinton